ARTICLE | Clinical News
CRS-207 regulatory update
April 13, 2015 7:00 AM UTC
FDA granted Orphan Drug designation to Aduro’s CRS-207 to treat mesothelioma. The live attenuated strain of Listeria monocytogenes that expresses human mesothelin is in Phase Ib testing for the indic...